MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH)

CUSIP: 57060U217

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / PHARMACEUTICAL
Total 13F shares
2,677,504
Share change
-708,593
Total reported value
$153,942,750
Price per share
$57.48
Number of holders
54
Value change
-$48,501,424
Number of buys
23
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 57060U217?
CUSIP 57060U217 identifies PPH - MARKET VECTORS ETF TR - PHARMACEUTICAL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) as of Q1 2016

As of 31 Mar 2016, MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,677,504 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, MORGAN STANLEY, Harel Insurance Investments & Financial Services Ltd., RAYMOND JAMES & ASSOCIATES, Virtu Financial LLC, ASPIRIANT, LLC, Clal Insurance Enterprises Holdings Ltd, BANK OF AMERICA CORP /DE/, CREDIT SUISSE AG/, and LPL Financial LLC. This page lists 54 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.